KLRD1 and Miyoshi myopathy: Since HDACis and alkylating agents have been reported to modulate the expression of ligands for activating NK cell receptors [24,26,28,29], we investigated the effect of tinostamustine on the expression of NKG2D and DNAM-1 ligands in several MM cell lines.